Pfizer files for U.S. authorization of its pill to treat COVID-19
Global News
Pfizer says that its COVID-19 treatment pill can help to significantly cut the risk of death or hospitalization in high-risk adults.
Pfizer Inc said on Tuesday it is seeking U.S. authorization of its experimental antiviral COVID-19 pill that cut the chance of hospitalization or death for adults at risk of severe disease by 89% in a clinical trial.
Pfizer said it completed submission of its application for emergency use authorization (EUA) of the drug, Paxlovid, with the U.S. Food and Drug Administration, including data from the drugmaker’s clinical trial.
The oral drug could be promising new weapon in the fight against the pandemic, as it can be taken as an early at-home treatment to help prevent COVID-19 hopitalizations and deaths. It could also become a important tool in countries and areas with limited access to vaccines or low vaccination rates.
It is not immediately clear when U.S. regulators will rule on Pfizer’s application. Merck & Co Inc and Ridgeback Biotherapeutics, which are developing a competing pill, molnupiravir, completed their EUA submission on Oct. 11.
A panel of outside advisers to the FDA will meet to consider that application on Nov. 30, and it is expected to be available this year.
“We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients, and we look forward to working with the U.S. FDA on its review of our application, along with other regulatory agencies around the world,” Pfizer Chief Executive Albert Bourla said in a news release.
The New York-based drugmaker said it has begun the process of seeking authorization in several countries including the United Kingdom, Australia, New Zealand and South Korea, and plans further international submissions.
Pfizer said earlier on Tuesday it will allow generic manufacturers to supply its COVID-19 pill to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP).
It was both a big win and hopefully not too big of a loss for the Edmonton Oilers on Sunday.
Some experts say that a cyberwar through 'proxies' may be the next stage of the Iran war, with civilian infrastructure also coming under threat.
The study is being billed by the university as "the first to study a wide range of factors which link ADHD symptoms and mental ill health symptoms over time."
The group says MAGA Energy hasn't paid its lease for three years, and therefore the company is no longer allowed on their land in Edmonton.
The analysis by the Canadian Climate Institute says oilsands producers will pay an average of about 50 cents per oil barrel, if the minimum carbon price rises to $130 per tonne.
Between November 29 and February 27, authorities recorded 406 outbreaks of bird flu in domestic birds in 32 European countries and 2,108 outbreaks in wild birds, they said.
Dr. Michael Domeier, director of the Marine Conservation Science Institute, told Global News that they tag the adult females as they are the most interesting.
Regina’s recycling contamination is currently triple the limit and city is urging resident to change sorting habits now to avoid citywide fines and higher resident fees.
The study found that higher ultra-processed food intake at age three years was associated with adverse behavioural and emotional symptoms at age five years.
Edmonton's single-use waste rules were controversial and unpopular when introduced in 2023 — but new data shows the changes are having the intended effect of reducing garbage.
Carney's speech to Australia's parliament highlighted a soon-to-launch Canadian low earth orbit satellite network that experts say could soon compete with Elon Musk's Starlink.
The Pentagon said in a statement Thursday that it has “officially informed Anthropic leadership the company and its products are deemed a supply chain risk, effective immediately.”
Opioid overdose deaths in Canada are falling, but there's growing concerns on a certain veterinary tranquilizer being cut into fentanyl and other opioids.